周围创伤性假性动脉瘤的治疗经验

目的：探讨不同方法治疗创伤性周围动脉假性动脉瘤的临床疗效。方法：采用超声引导下压迫、瘤腔内注射凝血酶,以及手术缝合破口,补片修补,血管移植等方法治疗周围创伤性假性动脉瘤18例。结果：超声引导下压迫、瘤腔注射凝血酶5例及手术治疗13例均获成功,无远端动脉缺血等严重并发症发生。术后复查显示假性动脉瘤消失,动静脉血流恢复正常。结论：周围创伤性假性动脉瘤应尽早处理,根据病变的具体情况选择合理的治疗方案。     

超声引导下球囊辅助注射外用冻干人纤维蛋白粘合剂治疗肱动脉假性动脉瘤1例

该文报道1例维持性血液透析患者行内瘘穿刺过程中误伤肱动脉引起假性动脉瘤(pseudoaneurysm, PSA)的救治。既往PSA主要治疗方式包括外科切开修补、局部加压治疗、超声引导下瘤腔内注射凝血酶、覆膜支架植入、弹簧圈栓塞等方法, 但均有一定缺陷。该患者因内瘘功能不良入院, 彩超确诊肱动脉PSA形成, 使用超声引导下球囊辅助注射外用冻干人纤维蛋白粘合剂成功治疗PSA。术后3个月回访患者, 内瘘功能良好。     

膝关节置换术腘动脉损伤的治疗体会

目的探讨膝关节置换术腘动脉损伤的原因及治疗方法。 方法回顾性分析2010年10月至2018年5月就诊于烟台市烟台山医院的6例膝关节置换术出现腘动脉损伤患者的临床资料,其中5例为腘动脉假性动脉瘤,1例为腘动脉血栓形成,腘动脉假性动脉瘤予以局部压迫、注射凝血酶、腘动脉修补治疗,腘动脉血栓形成予以置管溶栓治疗。 结果1例腘动脉血栓性形成经置管溶栓后动脉血流恢复,5例腘动脉假性动脉瘤经治疗后均消失,其中1例经局部加压,1例经局部注射凝血酶,3例经腘动脉修补治疗。 结论膝关节置换术腘动脉损伤的原因与患者自身基础疾病、血管条件及术中操作等有关,根据患者腘动脉损伤情况选择合适治疗方式可以得到有效的治疗。     

血管内球囊阻断和凝血酶注射治疗四肢假性动脉瘤

目的探讨血管内球囊阻断和凝血酶注射联合治疗四肢假性动脉瘤的临床应用。方法 8例四肢假性动脉瘤患者在血管造影基础上,在球囊阻断载瘤动脉并封闭假性动脉瘤漏口的同时,采用头皮针经皮直接穿刺动脉瘤,行瘤腔内注射凝血酶。结果 8例患者均一次性治疗成功,术中及术后造影,漏口闭塞,瘤腔内未见血流;术后无明显并发症,未见载瘤动脉远端急性动脉血栓形成。术后3～6个月随访假性动脉瘤均完全闭塞,无复发。结论血管内球囊阻断和凝血酶注射治疗假性动脉瘤创伤小,安全性高,疗效确切,可作为假性动脉瘤外科修补术的替代治疗方法。     

医源性股动脉假性动脉瘤的治疗方法

目的 评估超声引导下局部压迫和手术治疗医源性股动脉假性动脉瘤的疗效并介绍治疗经验.方法 1995年4月至2008年4月对197例医源性股动脉假性动脉瘤病人进行治疗,其中171例首选超声引导下局部压迫治疗(假性动脉瘤稳定者),26例(假性动脉瘤破裂或瘤腔直径≥40 mm者)直接手术治疗.结果 压迫治疗的171例中137例压迫成功,有效率80%,34例失败者改行手术治疗.直接手术治疗的26例及上述改行手术的34例中,47例行股动脉假性动脉瘤切除、动脉壁破口修补术,6例行自体大隐静脉补片成形术,7例行人工血管转流术.围手术期所有手术病例无出血、神经痛、淋巴瘘、动静脉瘘等严重并发症和死亡.随访1个月至5年,均未见假性动脉瘤复发或肢体缺血症状.随访期间无死亡.结论 局部压迫疗法治疗医源性股动脉假性动脉瘤安全、有效、经济,可作为大部分稳定病人的首选治疗方法.不适合压迫治疗者及压迫治疗失败的病人可手术治疗,疗效确切.     

创伤性周围假性动脉瘤的外科治疗分析

目的　探讨创伤性周围假性动脉瘤的诊断和治疗方法。方法　回顾性分析 5 8例创伤性周围假性动脉瘤。均手术治疗 ,其中动脉重建 17例 ,直接修补 2 9例 ,补片修补 6例 ,动脉结扎6例。结果　死亡 1例 ,其余 5 7例术后痊愈出院。随访 3 5例 ,均未截肢或出现脑缺血症状 ,3例移植血管闭塞 ,其余均保持通畅。结论　凡损伤性假性动脉瘤的诊断一经确定 ,应行手术治疗 ,以避免并发症的发生。阻断动脉血流是手术成败的关键 ,使用Fogarty导管简便易行 ,介入法置入气囊导管 ,也可阻断血流。防止假性动脉瘤的发生的最好方法是创伤早期对血管损伤的正确处理。     

1例假性动脉瘤患者瘤腔内注射凝血酶的护理

对1例假性动脉瘤患者在超声引导下局部注射凝血酶,注射后彩色多普勒血流显像示假性动脉瘤内血液凝固,血流信号消失.提示瘤腔内注射凝血酶治疗假性动脉瘤创伤小、效果好、安全易行.而完善术前准备,术中密切配合,术后加强并发症的观察是保证治疗成功的关键.     

1例假性动脉瘤患者瘤腔内注射凝血酶的护理

对1例假性动脉瘤患者在超声引导下局部注射凝血酶，注射后彩色多普勒血流显像示假性动脉瘤内血液凝固,血流信号消失。提示瘤腔内注射凝血酶治疗假性动脉瘤创伤小、效果好、安全易行。而完善术前准备，术中密切配合，术后加强并发症的观察是保证治疗成功的关键。     

超声引导下凝血酶注射术治疗股动脉假性动脉瘤的临床应用价值

目的探讨超声引导下瘤体内注射凝血酶治疗股动脉假性动脉瘤的临床价值。方法选取39例医源性股动脉穿刺后并发假性动脉瘤患者,均在超声引导下行瘤体内注射凝血酶治疗。结果 35例注射凝血酶剂量200~500 U,一次性成功。4例行二次注射成功,总成功率为100%(39/39)。24 h后复查彩超,瘤体内均未见血流信号。结论超声引导下经皮瘤体内注射凝血酶治疗股动脉假性动脉瘤,具有操作简便、效果可靠、并发症少、复发率低等优点,可作为股动脉假性动脉瘤的首选治疗方法。     

肱动脉假性动脉瘤腔内注射凝血酶的作用

探讨超声引导下假腔内注射凝血酶对肱动脉假性动脉瘤的治疗效果。资料与方法自2000年1月至2004年3月,3例尿毒症患者,穿刺透析后出现假性血管瘤,压迫观察24～48h无效后再采用假腔内注射凝血酶。男性1例,女性2例,年龄31～48岁。主要表现为穿刺肢体高度肿胀、疼痛、搏动性包块及震颤,听诊有血管杂音,彩色超声示病变部位有往返血流信号。用注射器在超声引导下刺入假瘤腔1cm,回抽见动脉血,在5～10s内注入内含500U凝血酶盐水1ml,拔针压迫穿刺点5min。超声显示肱动脉与假性动脉瘤之间的血流消失为成功,回病房后平卧、制动,患肢抬高6h。结果上述3例…     

Ipsilateral femoral vein compression: a contraindication to thrombin injection of femoral pseudoaneurysms

Development of a femoral artery pseudoaneurysm occurs in 0.6% to 3.2% of interventional procedures. Nonsurgical treatment has consisted of ultrasound scan-directed compression and, more recently, direct thrombin injection into the pseudoaneurysm cavity to achieve thrombosis. Reported complications after thrombin injection are rare. We report two cases of femoral venous compression associated with pseudoaneurysm injection and review the literature. A 76-year-old man and an 86-year-old man both underwent thrombin injection of pseudoaneurysms compressing the ipsilateral common femoral vein. Both patients were diagnosed with deep venous thrombosis and subsequently needed surgical exploration for repair of the pseudoaneurysm and release of the venous compression. At exploration, both were found to have significant inflammation surrounding the femoral vessels, which made vessel exposure challenging. Because of the venous outflow obstruction involved in femoral pseudoaneurysms with secondary venous compression and the surgical difficulty caused by surrounding inflammation, avoidance of thrombin injection in favor of early surgical intervention is suggested.     

Ultrasound-guided percutaneous thrombin injection for femoral artery pseudoaneurysms

We reviewed 13 cases of ultrasound-guided thrombin injection of femoral pseudoaneurysms. All cases occurred within a 17-month period from January 1998 through May 1999 and were complications of femoral artery puncture. Immediate total thrombosis occurred in nine of 13 patients. Twenty-four-hour follow-up ultrasound in seven patients revealed no recurrence of pseudoaneurysm. Two of 13 patients required operative repair. One pseudoaneurysm thrombosed with 15 minutes of compression after injection and one case required a second injection. No cases of arterial thrombosis were noted. Ultrasound-guided thrombin injection for femoral artery pseudoaneurysm represents a safe and effective alternative to operative repair.     

Percutaneous ultrasound guided thrombin injection: A new method for treating postcatheterization femoral pseudoaneurysms

Purpose: Since its introduction in 1991, ultrasound guided compression repair of postcatheterization femoral artery pseudoaneurysms has been shown to be effective. Disadvantages of ultrasound guided compression repair include patient discomfort during compression, inability to treat noncompressible pseudoaneurysms, prolonged use of ultrasound equipment and personnel, limited success with patients being treated with anticoagulants, and some early recurrences. We conducted a prospective study to evaluate a new method of treating femoral pseudoaneurysms, percutaneous ultrasound guided thrombin injection. Methods: Under duplex ultrasound guidance, a 22- or 25-gauge needle was percutaneously positioned within the pseudoaneurysm. Without compressing the pseudoaneurysm, 0.5 to 1 ml thrombin solution (1000 U/ml) was injected to induce thrombosis. Early in the study, the procedure was modified to allow more than one injection. After successful thrombosis, the patients were kept at rest in bed for at least 1 hour. Duplex ultrasound examination was repeated in 1 to 4 days. Distal pulses and ankle-brachial indexes were measured before and after the procedure. Results: Twenty of 21 consecutive pseudoaneurysms were successfully treated with thrombin injection. Fifteen pseudoaneurysms thrombosed immediately (<20 seconds) after one injection. The other five had partial thrombosis after one injection and complete thrombosis immediately after a second injection. The one failure occurred in a patient who had only one injection and then underwent subsequent ultrasound guided compression repair, which failed. No patient required sedation or analgesia during thrombin injection. There were no procedure-related complications and no recurrences. Conclusions: Percutaneous ultrasound guided thrombin injection appears to be a safe and expeditious method for treating postcatheterization femoral pseudoaneurysms. It has significant advantages with respect to ultrasound guided compression repair or surgical repair. (J Vasc Surg 1998;27:1032-8.)     

Treatment of arterial pseudoaneurysms with percutaneous ultrasound-guided thrombin injection

Background: The pseudoaneurysms or false aneurysms are one of the most common complications after arterial invasive manipulation. Different methods of treatment have been described, such as surgical repair, ultrasound-guided compression and endovascular procedures. Ultrasound-guided thrombin injection has shown efficacy, safety and low cost, and, in some cases, the procedure is considered the treatment of choice. Preliminary results are presented. Methods: Design: Case series. We studied adult patients with iatrogenic arterial pseudoaneurysms demonstrated clinically and corroborated with ultrasound. We describe the technique used for the management of the arterial pseudoaneurysms by ultrasound-guided thrombin application, as well as complications and follow-up. Results: Twelve patients were included with a mean age of 63 years (SD 12.4), 33% were male and 67% female. Associated comorbid states were hypertension 83%, 50% diabetes, obesity 66%. All pseudoaneurysms were located in the femoral artery (2:1 right/left ratio). The mean size of the pseudoaneurysm was 48.2 mm SD 11.9, (range of 30 to 65 mm) by 44.3 mm SD 9.3, (range 20 to 53 mm). The average neck diameter was 2.2 mm SD 0.54 (range of 1.5 to 3 mm). Eleven cases were unilobulated (87.5%), and one bilobulated (12.5%). All reported arterial integrity with complete occlusion after one thrombin application without recurrence and morbidity after 90 days of follow up. Conclusions: In our study we obtained a 100% of thrombosis without pseudoaneurysm recurrence or complications. However a longer follow-up time and more number of cases are required to confirm these results.     

Brachial artery pseudoaneurysm: a rare complication after haemodialysis therapy

Haemodialysis patients carry a high risk of pseudoaneurysm due to inadvertent puncture of the brachial artery during venous cannulation for haemodialysis. Signs and symptoms are pulsatile mass and a systolic murmur. Complications are rupture, infection, haemorrhage, distal arterial insufficiency, venous thrombosis and neuropathy. Early diagnosis is essential to plan adequate treatment. Doppler US and angiography usually confirm the lesion accurately. Ultrasound guided compression, percutaneous injection of thrombin, endovascular covered stent exclusion, aneurysmectomy and surgical repair are different treatment options. We report clinical and radiological findings and treatment strategies in four dialysed patients who developed brachial artery pseudoaneurysms.     

Brachial Artery Pseudoaneurysm: a Rare Complication after Haemodialysis Therapy

Haemodialysis patients carry a high risk of pseudoaneurysm due to inadvertent puncture of the brachial artery during venous cannulation for haemodialysis.

Signs and symptoms are pulsatile mass and a systolic murmur. Complications are rupture, infection, haemorrhage, distal arterial insufficiency, venous thrombosis and neuropathy. Early diagnosis is essential to plan adequate treatment. Doppler US and angiography usually confirm the lesion accurately. Ultrasound guided compression, percutaneous injection of thrombin, endovascular covered stent exclusion, aneurysmectomy and surgical repair are different treatment options.

We report clinical and radiological findings and treatment strategies in four dialysed patients who developed brachial artery pseudoaneurysms.     

颈外静脉移植治疗注射毒品所致的假性股动脉瘤

目的探讨注射毒品致假性股动脉瘤的临床特点及颈外静脉移植治疗的可行性。方法2002年6月~2006年2月,对注射毒品所致的20例假性股动脉瘤行手术治疗,并移植颈外静脉重建股动脉缺损。结果所有病例均成功保存肢体,无缺血坏死及小腿骨筋膜室综合征发生。伤口一期愈合9例,余11例出现淋巴漏,二期愈合4例,再次手术行局部皮瓣转移修复7例。1例因吻合口破裂出血而结扎股动脉,1例有股神经损伤的表现。16例随访1~24个月,无复发,足背动脉可扪及搏动,10例术后血管彩超显示移植的颈外静脉通畅。结论手术是治疗注射毒品所致的假性股动脉瘤唯一有效的方法;在瘤体切除后大隐静脉往往因炎症而不能利用,移植颈外静脉修复重建股动脉缺损是可行的。